Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
Stelljes M, Specht C, Albring J, Volkmann S, Schlösser V, Pauels HG, Poremba C, Bisping G, Opitz C, Scheffold C, Silling G, Kiehl M, Berdel WE, Kienast J.
Stelljes M, et al. Among authors: bisping g.
Transplantation. 2007 Feb 15;83(3):314-22. doi: 10.1097/01.tp.0000250725.95074.f1.
Transplantation. 2007.
PMID: 17297406